Revenue Summary of Bioasis Technologies Inc.

Bioasis Technologies Inc.'s latest annual revenue in 2023 was - CAD , down -100.0% from previous year.
Bioasis Technologies Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down 0.0% from previous quarter.
Bioasis Technologies Inc. reported a annual revenue of 37.72 Thousand CAD in annual revenue 2022, down -99.07% from previous year.
Bioasis Technologies Inc. reported a annual revenue of 4.07 Million CAD in annual revenue 2021, up 572.53% from previous year.
Bioasis Technologies Inc. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.
Bioasis Technologies Inc. reported a quarterly revenue of 148.93 Thousand CAD for 2023 Q3, up 23.66% from previous quarter.

Annual Revenue Chart of Bioasis Technologies Inc. (2023 - 2007)

Historical Annual Revenue of Bioasis Technologies Inc. (2023 - 2007)

Year	Revenue	Revenue Growth
2023	- CAD	-100.0%
2022	37.72 Thousand CAD	-99.07%
2021	4.07 Million CAD	572.53%
2020	606.38 Thousand CAD	-57.36%
2019	1.42 Million CAD	141.09%
2018	589.84 Thousand CAD	14.99%
2017	512.96 Thousand CAD	38.97%
2016	369.12 Thousand CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	- CAD	0.0%
2024 Q1	- CAD	0.0%
2023 Q3	148.93 Thousand CAD	23.66%
2023 Q1	- CAD	0.0%
2023 FY	- CAD	-100.0%
2023 Q4	- CAD	-100.0%
2023 Q2	120.44 Thousand CAD	0.0%
2022 Q2	- CAD	0.0%
2022 FY	37.72 Thousand CAD	-99.07%
2022 Q4	- CAD	-100.0%
2022 Q1	- CAD	0.0%
2022 Q3	37.72 Thousand CAD	0.0%
2021 Q2	4.07 Million CAD	0.0%
2021 FY	4.07 Million CAD	572.53%
2021 Q1	- CAD	-100.0%
2021 Q3	- CAD	-100.0%
2021 Q4	- CAD	0.0%
2020 Q1	192.36 Thousand CAD	29.06%
2020 Q4	36.95 Thousand CAD	-79.86%
2020 FY	606.38 Thousand CAD	-57.36%
2020 Q3	183.48 Thousand CAD	-6.48%
2020 Q2	196.2 Thousand CAD	2.0%
2019 Q1	48.68 Thousand CAD	-45.78%
2019 Q2	- CAD	-100.0%
2019 Q4	149.05 Thousand CAD	-87.83%
2019 Q3	1.22 Million CAD	0.0%
2019 FY	1.42 Million CAD	141.09%
2018 FY	589.84 Thousand CAD	14.99%
2018 Q4	89.78 Thousand CAD	-33.75%
2018 Q3	135.53 Thousand CAD	-6.12%
2018 Q2	144.37 Thousand CAD	-34.42%
2018 Q1	220.14 Thousand CAD	108.94%
2017 Q4	105.36 Thousand CAD	-21.56%
2017 FY	512.96 Thousand CAD	38.97%
2017 Q3	134.33 Thousand CAD	14.08%
2017 Q1	155.52 Thousand CAD	14.12%
2017 Q2	117.75 Thousand CAD	-24.29%
2016 Q3	65.77 Thousand CAD	0.0%
2016 Q4	136.28 Thousand CAD	107.19%
2016 FY	369.12 Thousand CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q1	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q3	- CAD	0.0%
2013 FY	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q1	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q4	- CAD	0.0%
2009 Q1	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q2	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2007 FY	- CAD	0.0%

Peer Revenue Comparison of Bioasis Technologies Inc.

Name	Revenue	Revenue Difference
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	100.0%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	100.0%
SQZ Biotechnologies Company	21.47 Million USD	100.0%
Evofem Biosciences, Inc.	18.21 Million USD	100.0%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	100.0%
Mesoblast Limited	5.9 Million USD	100.0%
Propanc Biopharma, Inc.	- USD	NaN%
Genus plc	668.8 Million USD	100.0%
VioQuest Pharmaceuticals, Inc.	- USD	NaN%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	100.0%
Marizyme, Inc.	645.81 Thousand USD	100.0%
ContraFect Corporation	- USD	NaN%
Nymox Pharmaceutical Corporation	- USD	NaN%
PsyBio Therapeutics Corp.	- USD	NaN%
Sienna Biopharmaceuticals, Inc.	- USD	NaN%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	100.0%
Intellipharmaceutics International Inc.	65.72 Thousand USD	100.0%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	100.0%
MultiCell Technologies, Inc.	49.32 USD	100.0%
Accustem Sciences Inc.	- USD	NaN%
RVL Pharmaceuticals plc	49.72 Million USD	100.0%
EV Biologics, Inc.	48.9 Thousand USD	100.0%
Q BioMed Inc.	284.35 Thousand USD	100.0%
Emmaus Life Sciences, Inc.	29.59 Million USD	100.0%
Neon Bloom, Inc.	- USD	NaN%
Mosaic ImmunoEngineering Inc.	- USD	NaN%
Biomind Labs Inc.	- USD	NaN%
TetraLogic Pharmaceuticals Corporation	- USD	NaN%
Pharming Group N.V.	245.31 Million USD	100.0%
Oncotelic Therapeutics, Inc.	70 Thousand USD	100.0%
Skye Bioscience, Inc.	- USD	NaN%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	100.0%
THC Farmaceuticals, Inc.	- USD	NaN%
Arch Therapeutics, Inc.	75.72 Thousand USD	100.0%
IMV Inc.	- USD	NaN%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	100.0%
Curative Biotechnology, Inc.	- USD	NaN%
GB Sciences, Inc.	- USD	NaN%
Alpha Cognition Inc.	- USD	NaN%
HST Global, Inc.	- USD	NaN%
CSL Limited	14.69 Billion USD	100.0%
Halberd Corporation	999.00 USD	100.0%
Enzolytics Inc.	52.79 Thousand USD	100.0%
Resverlogix Corp.	- USD	NaN%
Affymax, Inc.	1.36 Million USD	100.0%
SYBLEU INC	11.69 Thousand USD	100.0%
Nuo Therapeutics, Inc.	608.52 Thousand USD	100.0%
argenx SE	1.22 Billion USD	100.0%
MetaStat, Inc.	- USD	NaN%
Northwest Biotherapeutics, Inc.	1.93 Million USD	100.0%
Enzon Pharmaceuticals, Inc.	- USD	NaN%
Arno Therapeutics, Inc.	- USD	NaN%
RespireRx Pharmaceuticals Inc.	- USD	NaN%
GeneThera, Inc.	- USD	NaN%
Inhibitor Therapeutics, Inc.	- USD	NaN%
AVAX Technologies, Inc.	617.38 Thousand USD	100.0%
Zenith Capital Corp.	- USD	NaN%
Genscript Biotech Corporation	839.52 Million USD	100.0%
Ember Therapeutics, Inc.	- USD	NaN%
Anthera Pharmaceuticals, Inc.	- USD	NaN%
Sigyn Therapeutics, Inc.	- USD	NaN%
WPD Pharmaceuticals Inc.	- USD	NaN%
American Oriental Bioengineering, Inc.	145.09 Million USD	100.0%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	100.0%
Adynxx, Inc.	- USD	NaN%
Helix BioMedix, Inc.	997.72 Thousand USD	100.0%
GlobeStar Therapeutics Corporation	- USD	NaN%
VitaSpring Biomedical Co. Ltd.	- USD	NaN%
Capstone Therapeutics Corp.	48.35 Million USD	100.0%
Cotinga Pharmaceuticals Inc.	- USD	NaN%
BioStem Technologies, Inc.	16.68 Million USD	100.0%
ONE Bio Corp.	52.29 Million USD	100.0%
Reve Technologies, Inc.	- USD	NaN%
Burzynski Research Institute, Inc.	- USD	NaN%
Wesana Health Holdings Inc.	- USD	NaN%
Agentix Corp.	- USD	NaN%
LadRx Corporation	- USD	NaN%
Cell Source, Inc.	- USD	NaN%
ProtoKinetix, Incorporated	- USD	NaN%
Regen BioPharma, Inc.	236.56 Thousand USD	100.0%
Regen BioPharma, Inc.	236.56 Thousand USD	100.0%
NovAccess Global Inc.	- USD	NaN%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	100.0%
Itoco Inc.	- USD	NaN%
Rasna Therapeutics, Inc.	- USD	NaN%
Pathfinder Cell Therapy, Inc.	- USD	NaN%
Kadimastem Ltd	- USD	NaN%
Oncology Pharma Inc.	- USD	NaN%
Institute of Biomedical Research Corp.	- USD	NaN%
CytoDyn Inc.	- USD	NaN%
Claritas Pharmaceuticals, Inc.	- USD	NaN%
NDT Pharmaceuticals Inc.	- USD	NaN%
Mobile Lads Corp.	- USD	NaN%
NanoSphere Health Sciences Inc.	- USD	NaN%
Qrons Inc.	- USD	NaN%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	100.0%
Advanced Proteome Therapeutics Corporation	- USD	NaN%
Nascent Biotech, Inc.	- USD	NaN%
Rebus Holdings, Inc.	- USD	NaN%
ImmunoCellular Therapeutics, Ltd.	- USD	NaN%
International Stem Cell Corporation	7.78 Million USD	100.0%
Bioxytran, Inc.	- USD	NaN%
GlobeImmune, Inc.	- USD	NaN%
Predictive Technology Group, Inc.	- USD	NaN%
ProText Mobility, Inc.	- USD	NaN%
Cardax, Inc.	- USD	NaN%
VG Life Sciences Inc.	- USD	NaN%
Kaleido Biosciences, Inc.	- USD	NaN%
Advaxis, Inc.	13 Thousand USD	100.0%
Adhera Therapeutics, Inc.	- USD	NaN%
RenovaCare, Inc.	- USD	NaN%
Regnum Corp.	- USD	NaN%
Innovation Pharmaceuticals Inc.	- USD	NaN%
Neutra Corp.	39.53 Thousand USD	100.0%
Windtree Therapeutics, Inc.	- USD	NaN%
PureTech Health plc	3.33 Million USD	100.0%
Coeptis Therapeutics, Inc.	- USD	NaN%
IXICO plc	6.66 Million USD	100.0%
IntelGenx Technologies Corp.	1.03 Million USD	100.0%
Gelesis Holdings, Inc.	25.76 Million USD	100.0%
CSL Limited	14.8 Billion USD	100.0%
Cellectis S.A.	755 Thousand USD	100.0%

Global Stocks Search

Bioasis Technologies Inc. (BIOAF)

Revenue Summary of Bioasis Technologies Inc.

Annual Revenue Chart of Bioasis Technologies Inc. (2023 - 2007)

Historical Annual Revenue of Bioasis Technologies Inc. (2023 - 2007)

Peer Revenue Comparison of Bioasis Technologies Inc.